HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single-port laparoscopic fecal diversion: more than cosmetic benefits?

Abstract
Single-port laparoscopic surgery is usually performed on patients with minor comorbidities. The aim of the study was to evaluate feasibility and efficacy of single-port fecal diversion in patients who had previous abdominal operations or comorbidities. Between October 2010 and March 2012, 14 patients with a median age of 57 years were diverted. The reasons for diversion were perianal infection/abscess (n=5), anal incontinence (n=3), radiation proctitis (n=2), colovesical fistula causing sepsis (n=1), outlet obstruction of ileal S pouch (n=1), perforation during pouchoscopy (n=1), and peritoneal carcinomatosis with enterocutaneus fistula (n=1). Median estimated blood loss was 20 mL, operative time was 52 minutes, and length of hospital stay was 4 days. Two patients had ileus postoperatively. One patient had a parastomal hernia 4 months after diversion. Single-port laparoscopic fecal diversion is a safe and feasible operation for patients with significant comorbidities and a history of multiple abdominal operations.
AuthorsErman Aytac, Luca Stocchi, Ryan Williams, Feza H Remzi, Meagan M Costedio
JournalSurgical laparoscopy, endoscopy & percutaneous techniques (Surg Laparosc Endosc Percutan Tech) Vol. 24 Issue 4 Pg. e133-6 (Aug 2014) ISSN: 1534-4908 [Electronic] United States
PMID24710240 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Colostomy (methods)
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Laparoscopes
  • Laparoscopy (methods)
  • Length of Stay (trends)
  • Male
  • Middle Aged
  • Operative Time
  • Patient Satisfaction
  • Prospective Studies
  • Surgical Stomas
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: